Loading…
Silver Covalently Bound to Cyanographene Overcomes Bacterial Resistance to Silver Nanoparticles and Antibiotics
The ability of bacteria to develop resistance to antibiotics is threatening one of the pillars of modern medicine. It was recently understood that bacteria can develop resistance even to silver nanoparticles by starting to produce flagellin, a protein which induces their aggregation and deactivation...
Saved in:
Published in: | Advanced science 2021-06, Vol.8 (12), p.2003090-n/a |
---|---|
Main Authors: | , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c5572-6fed1f036a34c1cf27a73d163b9e9921a08c7e34e512a4d60e59d0b6d435b0ff3 |
---|---|
cites | cdi_FETCH-LOGICAL-c5572-6fed1f036a34c1cf27a73d163b9e9921a08c7e34e512a4d60e59d0b6d435b0ff3 |
container_end_page | n/a |
container_issue | 12 |
container_start_page | 2003090 |
container_title | Advanced science |
container_volume | 8 |
creator | Panáček, David Hochvaldová, Lucie Bakandritsos, Aristides Malina, Tomáš Langer, Michal Belza, Jan Martincová, Jana Večeřová, Renata Lazar, Petr Poláková, Kateřina Kolařík, Jan Válková, Lucie Kolář, Milan Otyepka, Michal Panáček, Aleš Zbořil, Radek |
description | The ability of bacteria to develop resistance to antibiotics is threatening one of the pillars of modern medicine. It was recently understood that bacteria can develop resistance even to silver nanoparticles by starting to produce flagellin, a protein which induces their aggregation and deactivation. This study shows that silver covalently bound to cyanographene (GCN/Ag) kills silver‐nanoparticle‐resistant bacteria at concentrations 30 times lower than silver nanoparticles, a challenge which has been so far unmet. Tested also against multidrug resistant strains, the antibacterial activity of GCN/Ag is systematically found as potent as that of free ionic silver or 10 nm colloidal silver nanoparticles. Owing to the strong and multiple dative bonds between the nitrile groups of cyanographene and silver, as theory and experiments confirm, there is marginal silver ion leaching, even after six months of storage, and thus very high cytocompatibility to human cells. Molecular dynamics simulations suggest strong interaction of GCN/Ag with the bacterial membrane, and as corroborated by experiments, the antibacterial activity does not rely on the release of silver nanoparticles or ions. Endowed with these properties, GCN/Ag shows that rigid supports selectively and densely functionalized with potent silver‐binding ligands, such as cyanographene, may open new avenues against microbial resistance.
Silver covalently bound to cyanographene sheets kills persistent bacteria, which are resistant to silver nanoparticles, at trace level concentrations. Owing to the strong and multiple dative bonds between the nitrile groups of cyanographene and silver, there is minimum silver ion leaching, leading eventually to an exceptional combination of antibacterial activity with cytocompatibility. |
doi_str_mv | 10.1002/advs.202003090 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_bac9ae460b8c4dc28d1491f922fda0e3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_bac9ae460b8c4dc28d1491f922fda0e3</doaj_id><sourcerecordid>2671794354</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5572-6fed1f036a34c1cf27a73d163b9e9921a08c7e34e512a4d60e59d0b6d435b0ff3</originalsourceid><addsrcrecordid>eNqFkktvEzEURi0EolXpliUaiXXC9WMe3iClKY9KFZUosLXu2HdSR5NxsCdB-fc4JETtBla27HOPPlsfY685TDmAeIdum6YCBIAEDc_YueC6mchGqeeP9mfsMqUlAPBS1oo3L9mZVFwrLcpzFu59v6VYzMMWexrGfldchc3gijEU8x0OYRFx_UADFXcZs2FFqbhCO1L02BdfKfk04mBpzx9VX_LUGuPobZ9hzK7ZMPrWh3ySXrEXHfaJLo_rBfv-8cO3-efJ7d2nm_nsdmLLshaTqiPHO5AVSmW57USNtXS8kq0mrQVHaGxNUlHJBSpXAZXaQVs5JcsWuk5esJuD1wVcmnX0K4w7E9CbPwchLswxomnRaiRVQdtY5axoHFead1qIziGQzK73B9d6067I2fxNEfsn0qc3g38wi7A1jRBKCciCt0dBDD83lEazDJs45PcbUdW81jm1-idVKqXqWnKdqemBsjGkFKk75eBg9q0w-1aYUyvywJvH6U_43w5kQB2AX76n3X90Znb9416UlZC_ATvOxJw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2544477319</pqid></control><display><type>article</type><title>Silver Covalently Bound to Cyanographene Overcomes Bacterial Resistance to Silver Nanoparticles and Antibiotics</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>Wiley Open Access</source><source>PubMed Central</source><creator>Panáček, David ; Hochvaldová, Lucie ; Bakandritsos, Aristides ; Malina, Tomáš ; Langer, Michal ; Belza, Jan ; Martincová, Jana ; Večeřová, Renata ; Lazar, Petr ; Poláková, Kateřina ; Kolařík, Jan ; Válková, Lucie ; Kolář, Milan ; Otyepka, Michal ; Panáček, Aleš ; Zbořil, Radek</creator><creatorcontrib>Panáček, David ; Hochvaldová, Lucie ; Bakandritsos, Aristides ; Malina, Tomáš ; Langer, Michal ; Belza, Jan ; Martincová, Jana ; Večeřová, Renata ; Lazar, Petr ; Poláková, Kateřina ; Kolařík, Jan ; Válková, Lucie ; Kolář, Milan ; Otyepka, Michal ; Panáček, Aleš ; Zbořil, Radek</creatorcontrib><description>The ability of bacteria to develop resistance to antibiotics is threatening one of the pillars of modern medicine. It was recently understood that bacteria can develop resistance even to silver nanoparticles by starting to produce flagellin, a protein which induces their aggregation and deactivation. This study shows that silver covalently bound to cyanographene (GCN/Ag) kills silver‐nanoparticle‐resistant bacteria at concentrations 30 times lower than silver nanoparticles, a challenge which has been so far unmet. Tested also against multidrug resistant strains, the antibacterial activity of GCN/Ag is systematically found as potent as that of free ionic silver or 10 nm colloidal silver nanoparticles. Owing to the strong and multiple dative bonds between the nitrile groups of cyanographene and silver, as theory and experiments confirm, there is marginal silver ion leaching, even after six months of storage, and thus very high cytocompatibility to human cells. Molecular dynamics simulations suggest strong interaction of GCN/Ag with the bacterial membrane, and as corroborated by experiments, the antibacterial activity does not rely on the release of silver nanoparticles or ions. Endowed with these properties, GCN/Ag shows that rigid supports selectively and densely functionalized with potent silver‐binding ligands, such as cyanographene, may open new avenues against microbial resistance.
Silver covalently bound to cyanographene sheets kills persistent bacteria, which are resistant to silver nanoparticles, at trace level concentrations. Owing to the strong and multiple dative bonds between the nitrile groups of cyanographene and silver, there is minimum silver ion leaching, leading eventually to an exceptional combination of antibacterial activity with cytocompatibility.</description><identifier>ISSN: 2198-3844</identifier><identifier>EISSN: 2198-3844</identifier><identifier>DOI: 10.1002/advs.202003090</identifier><identifier>PMID: 34194925</identifier><language>eng</language><publisher>Germany: John Wiley & Sons, Inc</publisher><subject>Anti-Bacterial Agents - therapeutic use ; Antibiotics ; antimicrobial ; Antimicrobial agents ; Bacteria ; Bacterial infections ; Bacterial Infections - drug therapy ; cytocompatibility ; Drug Resistance, Bacterial - drug effects ; Fourier transforms ; Graphene ; Metal Nanoparticles - chemistry ; Metal Nanoparticles - therapeutic use ; Nanomaterials ; Nanoparticles ; Nitrogen ; Silver ; Silver - chemistry ; Silver - therapeutic use ; silver resistant</subject><ispartof>Advanced science, 2021-06, Vol.8 (12), p.2003090-n/a</ispartof><rights>2021 The Authors. Advanced Science published by Wiley‐VCH GmbH</rights><rights>2021 The Authors. Advanced Science published by Wiley‐VCH GmbH.</rights><rights>2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5572-6fed1f036a34c1cf27a73d163b9e9921a08c7e34e512a4d60e59d0b6d435b0ff3</citedby><cites>FETCH-LOGICAL-c5572-6fed1f036a34c1cf27a73d163b9e9921a08c7e34e512a4d60e59d0b6d435b0ff3</cites><orcidid>0000-0003-4411-9348 ; 0000-0002-1066-5677 ; 0000-0003-4621-8868 ; 0000-0002-3147-2196</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2544477319/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2544477319?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,11562,25753,27924,27925,37012,44590,46052,46476,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34194925$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Panáček, David</creatorcontrib><creatorcontrib>Hochvaldová, Lucie</creatorcontrib><creatorcontrib>Bakandritsos, Aristides</creatorcontrib><creatorcontrib>Malina, Tomáš</creatorcontrib><creatorcontrib>Langer, Michal</creatorcontrib><creatorcontrib>Belza, Jan</creatorcontrib><creatorcontrib>Martincová, Jana</creatorcontrib><creatorcontrib>Večeřová, Renata</creatorcontrib><creatorcontrib>Lazar, Petr</creatorcontrib><creatorcontrib>Poláková, Kateřina</creatorcontrib><creatorcontrib>Kolařík, Jan</creatorcontrib><creatorcontrib>Válková, Lucie</creatorcontrib><creatorcontrib>Kolář, Milan</creatorcontrib><creatorcontrib>Otyepka, Michal</creatorcontrib><creatorcontrib>Panáček, Aleš</creatorcontrib><creatorcontrib>Zbořil, Radek</creatorcontrib><title>Silver Covalently Bound to Cyanographene Overcomes Bacterial Resistance to Silver Nanoparticles and Antibiotics</title><title>Advanced science</title><addtitle>Adv Sci (Weinh)</addtitle><description>The ability of bacteria to develop resistance to antibiotics is threatening one of the pillars of modern medicine. It was recently understood that bacteria can develop resistance even to silver nanoparticles by starting to produce flagellin, a protein which induces their aggregation and deactivation. This study shows that silver covalently bound to cyanographene (GCN/Ag) kills silver‐nanoparticle‐resistant bacteria at concentrations 30 times lower than silver nanoparticles, a challenge which has been so far unmet. Tested also against multidrug resistant strains, the antibacterial activity of GCN/Ag is systematically found as potent as that of free ionic silver or 10 nm colloidal silver nanoparticles. Owing to the strong and multiple dative bonds between the nitrile groups of cyanographene and silver, as theory and experiments confirm, there is marginal silver ion leaching, even after six months of storage, and thus very high cytocompatibility to human cells. Molecular dynamics simulations suggest strong interaction of GCN/Ag with the bacterial membrane, and as corroborated by experiments, the antibacterial activity does not rely on the release of silver nanoparticles or ions. Endowed with these properties, GCN/Ag shows that rigid supports selectively and densely functionalized with potent silver‐binding ligands, such as cyanographene, may open new avenues against microbial resistance.
Silver covalently bound to cyanographene sheets kills persistent bacteria, which are resistant to silver nanoparticles, at trace level concentrations. Owing to the strong and multiple dative bonds between the nitrile groups of cyanographene and silver, there is minimum silver ion leaching, leading eventually to an exceptional combination of antibacterial activity with cytocompatibility.</description><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibiotics</subject><subject>antimicrobial</subject><subject>Antimicrobial agents</subject><subject>Bacteria</subject><subject>Bacterial infections</subject><subject>Bacterial Infections - drug therapy</subject><subject>cytocompatibility</subject><subject>Drug Resistance, Bacterial - drug effects</subject><subject>Fourier transforms</subject><subject>Graphene</subject><subject>Metal Nanoparticles - chemistry</subject><subject>Metal Nanoparticles - therapeutic use</subject><subject>Nanomaterials</subject><subject>Nanoparticles</subject><subject>Nitrogen</subject><subject>Silver</subject><subject>Silver - chemistry</subject><subject>Silver - therapeutic use</subject><subject>silver resistant</subject><issn>2198-3844</issn><issn>2198-3844</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqFkktvEzEURi0EolXpliUaiXXC9WMe3iClKY9KFZUosLXu2HdSR5NxsCdB-fc4JETtBla27HOPPlsfY685TDmAeIdum6YCBIAEDc_YueC6mchGqeeP9mfsMqUlAPBS1oo3L9mZVFwrLcpzFu59v6VYzMMWexrGfldchc3gijEU8x0OYRFx_UADFXcZs2FFqbhCO1L02BdfKfk04mBpzx9VX_LUGuPobZ9hzK7ZMPrWh3ySXrEXHfaJLo_rBfv-8cO3-efJ7d2nm_nsdmLLshaTqiPHO5AVSmW57USNtXS8kq0mrQVHaGxNUlHJBSpXAZXaQVs5JcsWuk5esJuD1wVcmnX0K4w7E9CbPwchLswxomnRaiRVQdtY5axoHFead1qIziGQzK73B9d6067I2fxNEfsn0qc3g38wi7A1jRBKCciCt0dBDD83lEazDJs45PcbUdW81jm1-idVKqXqWnKdqemBsjGkFKk75eBg9q0w-1aYUyvywJvH6U_43w5kQB2AX76n3X90Znb9416UlZC_ATvOxJw</recordid><startdate>20210601</startdate><enddate>20210601</enddate><creator>Panáček, David</creator><creator>Hochvaldová, Lucie</creator><creator>Bakandritsos, Aristides</creator><creator>Malina, Tomáš</creator><creator>Langer, Michal</creator><creator>Belza, Jan</creator><creator>Martincová, Jana</creator><creator>Večeřová, Renata</creator><creator>Lazar, Petr</creator><creator>Poláková, Kateřina</creator><creator>Kolařík, Jan</creator><creator>Válková, Lucie</creator><creator>Kolář, Milan</creator><creator>Otyepka, Michal</creator><creator>Panáček, Aleš</creator><creator>Zbořil, Radek</creator><general>John Wiley & Sons, Inc</general><general>John Wiley and Sons Inc</general><general>Wiley</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7XB</scope><scope>88I</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>M2O</scope><scope>M2P</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-4411-9348</orcidid><orcidid>https://orcid.org/0000-0002-1066-5677</orcidid><orcidid>https://orcid.org/0000-0003-4621-8868</orcidid><orcidid>https://orcid.org/0000-0002-3147-2196</orcidid></search><sort><creationdate>20210601</creationdate><title>Silver Covalently Bound to Cyanographene Overcomes Bacterial Resistance to Silver Nanoparticles and Antibiotics</title><author>Panáček, David ; Hochvaldová, Lucie ; Bakandritsos, Aristides ; Malina, Tomáš ; Langer, Michal ; Belza, Jan ; Martincová, Jana ; Večeřová, Renata ; Lazar, Petr ; Poláková, Kateřina ; Kolařík, Jan ; Válková, Lucie ; Kolář, Milan ; Otyepka, Michal ; Panáček, Aleš ; Zbořil, Radek</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5572-6fed1f036a34c1cf27a73d163b9e9921a08c7e34e512a4d60e59d0b6d435b0ff3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibiotics</topic><topic>antimicrobial</topic><topic>Antimicrobial agents</topic><topic>Bacteria</topic><topic>Bacterial infections</topic><topic>Bacterial Infections - drug therapy</topic><topic>cytocompatibility</topic><topic>Drug Resistance, Bacterial - drug effects</topic><topic>Fourier transforms</topic><topic>Graphene</topic><topic>Metal Nanoparticles - chemistry</topic><topic>Metal Nanoparticles - therapeutic use</topic><topic>Nanomaterials</topic><topic>Nanoparticles</topic><topic>Nitrogen</topic><topic>Silver</topic><topic>Silver - chemistry</topic><topic>Silver - therapeutic use</topic><topic>silver resistant</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Panáček, David</creatorcontrib><creatorcontrib>Hochvaldová, Lucie</creatorcontrib><creatorcontrib>Bakandritsos, Aristides</creatorcontrib><creatorcontrib>Malina, Tomáš</creatorcontrib><creatorcontrib>Langer, Michal</creatorcontrib><creatorcontrib>Belza, Jan</creatorcontrib><creatorcontrib>Martincová, Jana</creatorcontrib><creatorcontrib>Večeřová, Renata</creatorcontrib><creatorcontrib>Lazar, Petr</creatorcontrib><creatorcontrib>Poláková, Kateřina</creatorcontrib><creatorcontrib>Kolařík, Jan</creatorcontrib><creatorcontrib>Válková, Lucie</creatorcontrib><creatorcontrib>Kolář, Milan</creatorcontrib><creatorcontrib>Otyepka, Michal</creatorcontrib><creatorcontrib>Panáček, Aleš</creatorcontrib><creatorcontrib>Zbořil, Radek</creatorcontrib><collection>Wiley Open Access</collection><collection>Wiley-Blackwell Free Backfiles(OpenAccess)</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>ProQuest research library</collection><collection>Science Database</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Advanced science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Panáček, David</au><au>Hochvaldová, Lucie</au><au>Bakandritsos, Aristides</au><au>Malina, Tomáš</au><au>Langer, Michal</au><au>Belza, Jan</au><au>Martincová, Jana</au><au>Večeřová, Renata</au><au>Lazar, Petr</au><au>Poláková, Kateřina</au><au>Kolařík, Jan</au><au>Válková, Lucie</au><au>Kolář, Milan</au><au>Otyepka, Michal</au><au>Panáček, Aleš</au><au>Zbořil, Radek</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Silver Covalently Bound to Cyanographene Overcomes Bacterial Resistance to Silver Nanoparticles and Antibiotics</atitle><jtitle>Advanced science</jtitle><addtitle>Adv Sci (Weinh)</addtitle><date>2021-06-01</date><risdate>2021</risdate><volume>8</volume><issue>12</issue><spage>2003090</spage><epage>n/a</epage><pages>2003090-n/a</pages><issn>2198-3844</issn><eissn>2198-3844</eissn><abstract>The ability of bacteria to develop resistance to antibiotics is threatening one of the pillars of modern medicine. It was recently understood that bacteria can develop resistance even to silver nanoparticles by starting to produce flagellin, a protein which induces their aggregation and deactivation. This study shows that silver covalently bound to cyanographene (GCN/Ag) kills silver‐nanoparticle‐resistant bacteria at concentrations 30 times lower than silver nanoparticles, a challenge which has been so far unmet. Tested also against multidrug resistant strains, the antibacterial activity of GCN/Ag is systematically found as potent as that of free ionic silver or 10 nm colloidal silver nanoparticles. Owing to the strong and multiple dative bonds between the nitrile groups of cyanographene and silver, as theory and experiments confirm, there is marginal silver ion leaching, even after six months of storage, and thus very high cytocompatibility to human cells. Molecular dynamics simulations suggest strong interaction of GCN/Ag with the bacterial membrane, and as corroborated by experiments, the antibacterial activity does not rely on the release of silver nanoparticles or ions. Endowed with these properties, GCN/Ag shows that rigid supports selectively and densely functionalized with potent silver‐binding ligands, such as cyanographene, may open new avenues against microbial resistance.
Silver covalently bound to cyanographene sheets kills persistent bacteria, which are resistant to silver nanoparticles, at trace level concentrations. Owing to the strong and multiple dative bonds between the nitrile groups of cyanographene and silver, there is minimum silver ion leaching, leading eventually to an exceptional combination of antibacterial activity with cytocompatibility.</abstract><cop>Germany</cop><pub>John Wiley & Sons, Inc</pub><pmid>34194925</pmid><doi>10.1002/advs.202003090</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-4411-9348</orcidid><orcidid>https://orcid.org/0000-0002-1066-5677</orcidid><orcidid>https://orcid.org/0000-0003-4621-8868</orcidid><orcidid>https://orcid.org/0000-0002-3147-2196</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2198-3844 |
ispartof | Advanced science, 2021-06, Vol.8 (12), p.2003090-n/a |
issn | 2198-3844 2198-3844 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_bac9ae460b8c4dc28d1491f922fda0e3 |
source | Publicly Available Content Database (Proquest) (PQ_SDU_P3); Wiley Open Access; PubMed Central |
subjects | Anti-Bacterial Agents - therapeutic use Antibiotics antimicrobial Antimicrobial agents Bacteria Bacterial infections Bacterial Infections - drug therapy cytocompatibility Drug Resistance, Bacterial - drug effects Fourier transforms Graphene Metal Nanoparticles - chemistry Metal Nanoparticles - therapeutic use Nanomaterials Nanoparticles Nitrogen Silver Silver - chemistry Silver - therapeutic use silver resistant |
title | Silver Covalently Bound to Cyanographene Overcomes Bacterial Resistance to Silver Nanoparticles and Antibiotics |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T16%3A52%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Silver%20Covalently%20Bound%20to%20Cyanographene%20Overcomes%20Bacterial%20Resistance%20to%20Silver%20Nanoparticles%20and%20Antibiotics&rft.jtitle=Advanced%20science&rft.au=Pan%C3%A1%C4%8Dek,%20David&rft.date=2021-06-01&rft.volume=8&rft.issue=12&rft.spage=2003090&rft.epage=n/a&rft.pages=2003090-n/a&rft.issn=2198-3844&rft.eissn=2198-3844&rft_id=info:doi/10.1002/advs.202003090&rft_dat=%3Cproquest_doaj_%3E2671794354%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5572-6fed1f036a34c1cf27a73d163b9e9921a08c7e34e512a4d60e59d0b6d435b0ff3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2544477319&rft_id=info:pmid/34194925&rfr_iscdi=true |